Recombinant monoclonal antibody to AOC3. Vapaliximab is a chimeric monoclonal antibody and an immunosuppressive drug.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Afuco™ Anti-AOC3 ADCC Recombinant Antibody (Vapaliximab), ADCC EnhancedThis product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to AOC3. Vapaliximab is a chimeric monoclonal antibody and an immunosuppressive drug.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-3906z | Mouse Anti-AOC3 Recombinant Antibody (clone 40D3) | WB, ELISA, FC, IHC, IP | Mouse IgG2a, κ |
HPAB-1627LY | Mouse Anti-AOC3 Recombinant Antibody (clone 1G3) | ELISA | Mouse IgG |
HPAB-1628LY | Mouse Anti-AOC3 Recombinant Antibody (clone 3F10) | ELISA | Mouse IgG |
HPAB-1629LY | Mouse Anti-AOC3 Recombinant Antibody (clone 3G6) | ELISA | Mouse IgG |
FAMAB-1004CQ | Mouse Anti-AOC3 Recombinant Antibody (clone 2D10) | IP, WB, ELISA, FC, IHC | Mouse IgG1 |
There are currently no Customer reviews or questions for TAB-261. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.